(0.27%) 5 475.09 points
(0.13%) 39 170 points
(0.83%) 17 879 points
(0.14%) $83.50
(0.00%) $2.48
(0.15%) $2 342.40
(0.53%) $29.77
(0.43%) $993.00
(0.05%) $0.931
(0.15%) $10.66
(0.04%) $0.791
(0.01%) $86.76
Live Chart Being Loaded With Signals
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders...
Stats | |
---|---|
Today's Volume | 46 938 |
Average Volume | 98 083 |
Market Cap | 92.63M |
EPS | $-0.720 ( Q1 | 2024-05-08 ) |
Next earnings date | ( $0 ) 2024-08-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.980 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00700 (0.23%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-24 | Traversa Sergio | Buy | 122 358 | Stock Option (right to buy) |
2024-05-24 | Traversa Sergio | Sell | 122 358 | Stock Option (right to buy) |
2024-05-24 | Shenouda Maged | Buy | 54 624 | Stock Option (right to buy) |
2024-05-24 | Shenouda Maged | Sell | 54 624 | Stock Option (right to buy) |
2024-05-24 | Kelly Paul Edward | Buy | 43 700 | Stock Option (right to buy) |
INSIDER POWER |
---|
50.55 |
Last 97 transactions |
Buy: 7 264 193 | Sell: 2 222 543 |
Volume Correlation
Relmada Therapeutics Inc Correlation
10 Most Positive Correlations | |
---|---|
ORMP | 0.906 |
MORF | 0.88 |
PCVX | 0.868 |
VXRT | 0.862 |
CSX | 0.859 |
ADVM | 0.848 |
FAT | 0.844 |
ROST | 0.836 |
CRSP | 0.835 |
MGRC | 0.832 |
10 Most Negative Correlations | |
---|---|
RGLD | -0.806 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Relmada Therapeutics Inc Correlation - Currency/Commodity
Relmada Therapeutics Inc Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-3.28 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-3.28 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-5.30 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-8.06 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Relmada Therapeutics Inc
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder in adults. The company was founded in 2004 and is headquartered in Coral Gables, Florida.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators